U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7710177101Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid SequencingRecruitingNo Results AvailableCutaneous Lymphoma|Other Skin Disorders|Mycosis Fungoides|Cutaneous T-cell Lymphomahttps://ClinicalTrials.gov/show/NCT01556828
7710277102Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaNot yet recruitingNo Results AvailablePHENYTOIN/SORAFENIB [VA Drug Interaction]|Liver Neoplasms|Carcinoma, Hepatocellular|Digestive System Neoplasms|Neoplasms by Site|Liver Diseases|Adenocarcinoma|Carcinoma|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|DOXORUBICIN/TRASTUZUMProcedure: Transarterial Chemoembolization (TACE)|Other: Sorafenib in combination with TACEhttps://ClinicalTrials.gov/show/NCT01556815
7710377103Use of Minocicline in Patients With StrokeRecruitingNo Results AvailableStroke|Brain Ischemia|ParalysisDrug: Minocicline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01556802
7710477104Phase 1 Study of ONT-10 in Patients With Solid TumorsCompletedNo Results AvailableSolid TumorsBiological: ONT-10https://ClinicalTrials.gov/show/NCT01556789
7710577105A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line TherapyRecruitingNo Results AvailableChronic Lymphocytic LeukemiaDrug: lenalidomide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01556776
7710677106Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With SchizophreniaCompletedHas ResultsSchizophrenia|Schizoaffective Disorder|Central Nervous System DiseasesDrug: EVP-6124 (0.3 mg/day)|Drug: EVP-6124 (1.0 mg/day)|Drug: Placebo|Drug: Antipsychotic therapyhttps://ClinicalTrials.gov/show/NCT01556763
7710777107[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01556750
7710877108Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal WomenCompletedNo Results AvailablePostmenopauseDietary Supplement: High daidzein supplement|Dietary Supplement: High genistein supplementhttps://ClinicalTrials.gov/show/NCT01556737
7710977109A Comparison of Postoperative Analgesic Nerve Block Ropivacaine ConcentrationsActive, not recruitingNo Results AvailableTotal Hip Arthroplasty|Postoperative PainDrug: 0.1% or 0.2% ropivacaine nerve blockshttps://ClinicalTrials.gov/show/NCT01556724
7711077110Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® TechnologyCompletedNo Results AvailableBrain Injuries|Craniocerebral Traumahttps://ClinicalTrials.gov/show/NCT01556711
7711177111Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne VulgarisCompletedNo Results AvailableAcne Vulgaris|AcneDrug: NVN1000 Topical Gel|Drug: Topical Gel Vehiclehttps://ClinicalTrials.gov/show/NCT01556698
7711277112MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and ColombiaCompletedNo Results AvailableMultiple SclerosisOther: clinical and neurological evaluation|Other: Blood Sample|Genetic: Blood Samplehttps://ClinicalTrials.gov/show/NCT01556685
7711377113Adalimumab-psoriasis and Small Bowel LesionsRecruitingNo Results AvailablePlaque Psoriasis|Crohn's DiseaseDrug: Adalimumab|Device: Capsule endoscopyhttps://ClinicalTrials.gov/show/NCT01556672
7711477114LV Thrombus After Acute AMI: A Randomized Controlled TrialRecruitingNo Results AvailableVentricular Thrombosis Mural Following Myocardial InfarctionDrug: Absence of Acenocoumarolhttps://ClinicalTrials.gov/show/NCT01556659
7711577115Effect of Tolvaptan on Cognitive Function in CirrhosisCompletedNo Results AvailableCirrhosis|Hepatic Encephalopathy|HyponatremiaDrug: Tolvaptanhttps://ClinicalTrials.gov/show/NCT01556646
7711677116A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine ClearanceCompletedNo Results AvailableHealthy VolunteerDrug: Tamiflu (oseltamivir)|Drug: Tamiflu (oseltamivir)https://ClinicalTrials.gov/show/NCT01556633
7711777117Is NIRS Able to Detect Ischemia Following Brain InsultCompletedNo Results AvailableBrain Trauma|SAH|ICHhttps://ClinicalTrials.gov/show/NCT01556620
7711877118A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, AsthmaCompletedNo Results AvailableDrug SafetyDrug: MDT-637|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01556607
7711977119Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaCompletedHas ResultsHypoglycemiaDrug: glucagon|Drug: Low dose novel formulation|Drug: high dose novel formulation|Drug: Medium dose novel formulationhttps://ClinicalTrials.gov/show/NCT01556594
7712077120Comparative Effectiveness of Early Physical Therapy Versus Usual Care for Low Back PainRecruitingNo Results AvailableLow Back PainProcedure: Usual Care|Procedure: Early Physical Therapyhttps://ClinicalTrials.gov/show/NCT01556581
7712177121Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic CardiomyopathyRecruitingNo Results AvailableCardiomegalyDrug: MEK162https://ClinicalTrials.gov/show/NCT01556568
7712277122Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)CompletedNo Results AvailableSclerosing Cholangitishttps://ClinicalTrials.gov/show/NCT01556555
7712377123Drug Eluting Balloon in peripherAl inTErvention SFACompletedNo Results AvailablePeripheral Arterial DiseaseDevice: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation|Device: nitinol stent implantationhttps://ClinicalTrials.gov/show/NCT01556542
7712477124CDRM Study: Computer-assisted Diabetes Risk Management-for Secondary and Tertiary Prevention of T2DM ComplicationsCompletedNo Results AvailableDiabetes Mellitus Type 2Procedure: risk profile information|Procedure: standard DMP care|Procedure: standard DMP carehttps://ClinicalTrials.gov/show/NCT01556529
7712577125Pregnancy and Birth Outcome in Women With Pompe DiseaseActive, not recruitingNo Results AvailablePompe Diseasehttps://ClinicalTrials.gov/show/NCT01556516
7712677126Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma DiagnosisActive, not recruitingNo Results AvailableMelanomaDevice: VivaScope Systemhttps://ClinicalTrials.gov/show/NCT01556503
7712777127Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver CancerRecruitingNo Results AvailableUnresectable Hepatocellular CarcinomaDevice: TheraSpherehttps://ClinicalTrials.gov/show/NCT01556490
7712877128The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).RecruitingNo Results AvailableMyelodysplastic Syndrome|Acute Myelogenous LeukemiaDrug: Azacitidine|Drug: azacitidine + lenalidomidehttps://ClinicalTrials.gov/show/NCT01556477
7712977129Initiation of Auto-adjusting CPAP for Newly Diagnosed OSA in Hospitalized PatientsTerminatedNo Results AvailableObstructive Sleep ApneaDevice: Auto-adjusting CPAPhttps://ClinicalTrials.gov/show/NCT01556464
7713077130ZOSTAVAXâ„¢ Safety and Immunogenicity in Korean Adults (V211-034)CompletedHas ResultsHerpes Zoster|ShinglesBiological: Zoster Vaccine Livehttps://ClinicalTrials.gov/show/NCT01556451

* Görseller ve İçerik tekif hakkına sahip olabilir